MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$85,112
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from short-term convert...
Accretion of original issuance c...
Accrued payroll and payroll taxe...
Others
Negative Cash Flow Breakdown
Net loss
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-578,503
-2,119,751
Depreciation expense
0
1,363
Stock based compensation
50,000
100,000
Accretion of debt discount
-70,211
-69,879
Accretion of original issuance costs
119,739
175,370
Modification of warrants
0
17,505
Inducement of preferred shares
0
845,901
Settlement of lease
0
5,798
Other current assets
-1,300
-7,697
Other assets
0
-20,711
Accounts payable
43,758
121,462
Accrued payroll and payroll taxes
93,645
317,113
Other current liabilities
524
1,666
Net cash used in operating activities
-199,326
-446,882
Advance from shareholder
-
0
Repayments of advance from shareholder
-
0
Proceeds from short-term convertible notes
281,438
425,197
Proceeds from short-term promissory notes
3,000
10,000
Net cash provided by financing activities
284,438
435,197
Net increase in cash
85,112
-11,685
Cash and cash equivalents at beginning of period
12,144
-
Cash and cash equivalents at end of period
85,571
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from short-term
convertible notes
$281,438
Proceeds from short-term
promissory notes
$3,000
Net cash provided by
financing activities
$284,438
Net increase in cash
$85,112
Canceled cashflow
$199,326
Accretion of original
issuance costs
$119,739
Accrued payroll and
payroll taxes
$93,645
Accretion of debt discount
-$70,211
Stock based
compensation
$50,000
Accounts payable
$43,758
Other current assets
-$1,300
Other current
liabilities
$524
Net cash used in
operating activities
-$199,326
Canceled cashflow
$379,177
Net loss
-$578,503
Buy us a coffee
Sigyn Therapeutics, Inc. (SIGY)
Sigyn Therapeutics, Inc. (SIGY)